Circulating DNA fragmentomics and cancer screening
Summary: The high fragmentation of nuclear circulating DNA (cirDNA) relies on chromatin organization and protection or packaging within mononucleosomes, the smallest and the most stabilized structure in the bloodstream. The detection of differing size patterns, termed fragmentomics, exploits informa...
Saved in:
Main Author: | A.R. Thierry (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fragmentomics of plasma mitochondrial and nuclear DNA inform prognosis in COVID-19 patients with critical symptoms
by: Haiqiang Zhang, et al.
Published: (2024) -
Circulating cell-free DNA and circulating tumor cells, the "liquid biopsies" in ovarian cancer
by: Xianliang Cheng, et al.
Published: (2017) -
The Utility of Circulating Tumor DNA (ctDNA) Monitoring in Cancer Patients Who Are Pregnant or Planning to Become Pregnant
by: Stacey A. Cohen, et al.
Published: (2022) -
Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer
by: Fang Yang, et al.
Published: (2021) -
Circulating cell-free DNA biomarkers
by: Jose Rafael Villarreal Escorcia
Published: (2021)